(Stroke. 1996;27:490-497.)
© 1996 American Heart Association, Inc.
Articles |
From the Departments of Neurology (K.R.W., Y.H., R.E.M., J.P.B., T.G.B.) and Pathology and Laboratory Medicine (G.X., G.M. de C.-M.), University of Cincinnati College of Medicine, and Medical Research Service (K.R.W., M.K., R.E.M.), Department of Veterans Affairs Medical Center, Cincinnati, Ohio.
| Abstract |
|---|
|
|
|---|
Methods We produced lobar hematomas by pressure-controlled infusions of 1.7 mL of autologous blood into the right frontal hemispheric white matter over 15 minutes. We froze brains in situ at 1, 3, 5, and 8 hours after hematoma induction and cut coronal sections for hematoma assessment, morphological brain examination, and immunohistochemical and water content determinations.
Results At 1 hour after blood infusion, "translucent" white matter areas were present directly adjacent to the hematoma. These markedly edematous regions had a greater than 10% increase in water content (>85%) compared with the contralateral white matter (73%), and this increased water content persisted through 8 hours. In addition, these areas were strongly immunoreactive for serum proteins. Intravascular Evans blue dye failed to penetrate into the brain tissue at all time points, demonstrating that this serum protein accumulation and edema development were not due to increased blood-brain barrier permeability.
Conclusions Experimental lobar ICH in pigs models a prominent pathological feature of human ICH, ie, early perihematomal edema. Our findings suggest that serum proteins, originating from the hematoma, accumulate in adjacent white matter and result in rapid and prolonged edema after ICH. This interstitial edema likely corresponds to the low densities on CT scans and the hyperintensities on T2-weighted MR images that surround intracerebral hematomas acutely after human ICH.
Key Words: brain edema cerebral hemorrhage white matter pigs
| Introduction |
|---|
|
|
|---|
To effectively treat ICH, a better understanding of the pathophysiological and pathochemical mechanisms that lead to brain injury from ICH is necessary. To study these mechanisms, we have developed a large-animal model of ICH in pigs. To avoid unphysiological conditions and to have well-contained, reproducible hematomas for pathophysiological, biochemical, and surgical removal studies, we chose to produce lobar hematomas and to infuse blood over 15 minutes rather than by rapid injections.5 6 7 8 This method reduces the likelihood of ventricular rupture or reflux of blood along the needle track that can lead to subarachnoid and subdural blood accumulations,6 7 8 and it also avoids severe mechanical trauma. Furthermore, slower blood infusion protocols compared with rapid infusions at high pressures more closely model human brain ICH. Such bleeds generally originate from small intraparenchymal arteries and occur at lower rates and pressures than those from ruptured aneurysms that bleed into the subarachnoid space at arterial pressures.4 This conclusion is also supported by the "gradual or smooth" time course of signs and symptoms that develop in the majority of ICH cases.4 Recently, slower blood infusions with improved hematoma productions were also described in rats by Hoff and coworkers.9
We chose to use the pig as an animal model and to produce lobar hematomas for several reasons. The pig's large, gyrated brain, well-developed white matter, uniform health status, and relatively low cost make it an excellent animal model for lobar ICH studies. The ability to use 20- to 30-fold larger ICH volumes in the pig compared with rodent species5 7 (recent studies use 2.5-mL infusion volumes10 11 ) enables examination of surgical hematoma removal. Infusions into the subcortical white matter rather than the gray matter of the basal ganglia result in more reproducible hematoma volumes, since blood more easily dissects between myelinated fibers12 than through the tight neuropil of gray matter structures. In addition, the greater white matter volume in large animals enables serum to accumulate and edema to develop adjacent to hematomas. This model is clinically relevant, since the frequency of lobar ICH is second only to putaminal ICH and is as common as or more common than thalamic hemorrhage.4 In younger patients, aged 15 to 45 years, lobar ICH is reported to be the most frequent site.4 13
In the present report we describe our initial findings with a model of lobar ICH in pigs. Preliminary reports of these findings have been presented.10 11 14 15
| Materials and Methods |
|---|
|
|
|---|
Animals
Pigs (weight, 6 to 8 kg) were obtained from a local
farm (John
Erickson Company, Dillsboro, Ind). Preoperatively, all pigs were
allowed food and water ad libitum. Pigs were not deprived of food
overnight before the experimental procedure because preliminary results
showed their strong tendency to develop marked hypoglycemia during
longer procedures (>5 hours).
Animal Surgical Preparation
The surgical procedures for
physiological
monitoring (tracheotomy, femoral vessel
catheterization) were similar to those described
previously by our laboratory for other large-animal
species.16 17 18 19 20
All surgical procedures were performed with
the use of aseptic techniques. Pigs were initially anesthetized
with ketamine (25 to 30 mg/kg) IM. After sedation,
pentobarbital (35 mg/kg) was administered through an ear vein to
achieve a deep surgical level of anesthesia. After
placement of the femoral vein catheter, pentobarbital was infused at a
rate of 10 mg/kg per hour throughout the remainder of the
experiment.
After surgical anesthesia was achieved, a tracheotomy was quickly performed and a cuffed endotracheal tube inserted and the cuff inflated. Pigs were then mechanically ventilated with the use of a pediatric respirator, and the respirator rate and tidal volume were adjusted to achieve arterial blood gases and pH within physiological limits (PO2, 100 to 150; PCO2, 35 to 40 mm Hg; pH, 7.40 to 7.50). The right femoral artery was catheterized for continuous blood pressure monitoring and to permit withdrawal of blood samples (0.3 mL) for determinations of respiratory gas and acid-base status and glucose concentrations (0.3 mL). A right femoral vein catheter was also placed to infuse saline solutions and to inject pharmacological agents. Core temperature was measured with a rectal thermistor probe and was maintained at 38.5±0.5°C with the use of a warm water blanket. Arterial blood samples were withdrawn during the control period, and hourly after ICH production up to the time of brain freezing. They were analyzed for PO2, PCO2, pH, and base deficit with the use of a Corning model 168 acid-base and respiratory gas analyzer. Serum was separated by centrifugation in a Beckman microfuge, and serum glucose concentrations were determined with the use of a Beckman Glucose Analyzer II.
Intracerebral Blood Infusion
Before blood infusion, the
animal's head was shaved and
disinfected, and full aseptic techniques were used. A cranial burr hole
(1.5 mm) was then drilled 10 mm to the left of the sagittal and 10 mm
anterior to the coronal suture. A 20-gauge sterile plastic catheter cut
to a length of 14 mm was then placed stereotaxically
(guided by the pig brain atlas of Yoshikawa21 ) into the
center of the left frontal cerebral white matter (centrum
semiovale) at the level of the caudate nucleus and cemented in
place. A 300-mm-long silicone elastomer tubing (Sil-Med) connected
to the arterial catheter was filled with 10 mL of
arterial blood by opening a three-way stopcock. A
pressure-controlled IVAC infusion pump was then connected, and 1.7
mL of blood was infused into the brain tissue over 15 minutes.
Evans Blue Infusions
To test BBB permeability to
albumin-bound Evans blue
dye, we infused Evans blue (1 mL/kg IV, 2% wt/vol solution; Clasen et
al22 ) immediately after the completion of the
intracerebral blood infusion. Three animals were
infused at each time point. After in situ brain freezing (described
below), brain sections were examined grossly for Evans blue staining
(Fig 5
). To determine whether albumin-bound Evans blue was
extravasated from the clot and permeated the extracellular space, we
infused Evans blue IV (1 mL/kg) at 30 minutes before removing the
arterial blood sample for intracerebral
injection. Brains of these animals (n=2) were then frozen at 8 hours
after blood infusion (Fig 6
).
|
|
CTP Recording
A Millar microtip pressure transducer was used
to measure CTP.
The catheter tip was inserted into the brain to a depth of 2 mm through
a 1-mm burr hole in the skull placed 10 mm posterior to the ICH
injection site. An 18-gauge stainless steel needle guide was cemented
in place through the burr hole to direct the catheter tip for brain
penetration. The CTP was continuously recorded along with blood
pressure and heart rate. All CTP recordings showed complex
waveforms that reflected the superimposition of the pressure waves of
both blood pressure and respiration (Fig 1
). These recordings
remained drift-free throughout the periods of recording.
Previous brain pathology studies showed only a minute penetrating
cortical lesion corresponding to catheter tip penetration.
|
Brain Tissue Fixation and Sampling
One, 3, 5, or 8 hours
(n=5 each except n=6 at 8 hours) after ICH
production, brains were frozen in situ by decanting liquid
nitrogen into a stainless steel cap adhered to the skull with
Dow-Corning silicone grease as described previously by us for several
large-animal
species.16 17 18 19 The
frozen heads were then
cut with a band saw into 5-mm-thick coronal sections in a
low-temperature room (-10°C). Coronal slices were examined
for hematoma location and volume measurements and for Evans blue
penetration. Tissue was then sampled for water content determinations
or immunohistochemical studies in a refrigerated glove box
(-20°C) from the coronal sections at specific white matter
sites identified by their relation to the hematoma. These sites
included "translucent" and "normal-appearing" white
matter directly adjoining the hematoma (Fig 2
), posterior
ipsilateral
white matter (centrum semiovale) located on the first coronal
slice posterior to the hematoma and/or edema, and corresponding
contralateral gyral white matter.
|
Immunohistochemistry
Direct immunofluorescence for fibrinogen
and
complement or immunoperoxidase for albumin was performed on
cryostat sections by standard methods23 24 on in situ
frozen brain tissue samples (n=3) at 1 hour after hematoma
induction.
Brain Tissue Water Contents
Edema was quantitated by
determining the water content of white
matter samples listed above by weighing and then drying the samples at
100°C for more than 24 hours to a constant weight. Water contents
were expressed as a percentage of wet weight.
Statistical Analysis
Data from different animal groups and
brain sites were
analyzed with a one-way ANOVA (Statgraphics, Manugistics,
Inc). Post hoc comparisons between groups were made with Duncan's
multiple range test. Differences were considered significant at
P<.05.
| Results |
|---|
|
|
|---|
Physiological parameters were
recorded at the end of the control period and then hourly after
infusion (Table
). No significant differences were
observed for arterial blood gases and pH at any time
points. No differences were present between postinfusion values for
core temperature; however, all values were slightly but significantly
higher than control. Cerebral perfusion pressure, calculated as
MABP-CTP, was maintained greater than 80 mm Hg at all time points
after infusion.
|
Fig 1
shows an example of the CTP and MABP tracings
during blood infusion. In this animal, CTP rose rapidly within the
first 3 minutes to 15 mm Hg and then gradually increased to a mean
value of 28 mm Hg by 7.5 minutes of infusion. CTP remained at this
level until the end of the 15-minute infusion. Blood pressure in the
animal in Fig 1
also increased gradually during infusion, from
a mean
value of 90 at the start to 105 mm Hg by the end of the infusion.
Mean values (±SD) for the change in CTP from control values
(
CTP) after infusion are presented in the Table
. When the
infusion was stopped, the mean value for
CTP fell to 3.8±2.3 mm Hg
at 1 hour after infusion. Thereafter, CTP averaged approximately 6 mm
Hg through 8 hours after infusion.
Size and Appearance of Hematomas,
Immunofluorescence, and Evans Blue
Staining
We successfully infused 1.7 mL of autologous blood into the
centrum semiovale near the caudate nucleus in 21 of 23 animals.
In 2 animals that were excluded, hematoma sizes were substantially
smaller (<0.25 mL), apparently as a result of blood loss along the
needle track and into the subarachnoid space. Hematoma sizes
were similar (no significant differences) at the four time points;
average hematoma volumes were as follows (mean±SD): 1.26±0.36 mL
(n=5) at 1 hour, 1.57±0.47 mL (n=5) at 3 hours,
1.60±0.58 mL (n=5) at
5 hours, and 1.19±0.37 mL (n=6) at 8 hours after infusion.
Hematomas were consistently located in the white matter of the
centrum semiovale at the level of the caudate nucleus and
anterior thalamus (Figs 2, 5, 6) and extended into the gyral white
matter to the frontal pole (Fig 3
). In all animals studied, we
observed
white matter regions adjacent to hematomas (referred to as translucent)
that were visibly changed in appearance (Fig 2
) because
of marked edema (demonstrated by water content measurements in Fig
8
).
Other white matter regions, also located adjacent but medial to
hematomas, appeared normal but were mildly edematous by water content
determinations compared with posterior or contralateral subcortical
white matter (referred to as normal-appearing). In coronal sections
through the ipsilateral anterior pole white matter, we also observed
substantial edema development (Fig 3
). This edema
accumulation presumably resulted from fluid movement in the
extracellular space along white matter fiber tracts toward the frontal
pole from the posterior extent of the hematoma. These 1.7-mL blood
infusions resulted in a mass effect sufficient to cause bilateral
herniation of cerebral hemispheric tissue and produce lateral
compression against the superior colliculi (Fig 4
).
|
|
|
Fig
5
illustrates a hematoma at 8 hours after 1.7-mL
intracerebral blood infusion. In this animal, Evans
blue was administered intravenously immediately after hematoma
induction. No blue staining of the edematous white matter surrounding
the hematoma was observed, suggesting that the BBB remained intact to
plasma proteins. In contrast, when Evans blue was administered
intravenously before the arterial blood for
intracerebral injection was removed, diffuse blue
staining of the white matter resulted as albumin with bound
Evans blue was extravasated from the hematoma into the surrounding
white matter (Fig 6
). The presence of plasma proteins in
the surrounding white matter was further demonstrated by immunopositive
reactions for fibrinogen (Fig 7
), complement, and albumin (not
shown). A striking immunofluorescence for
fibrinogen was observed in translucent white matter adjacent to the
hematoma at 1 hour after blood infusion (Fig 7
). This
appearance is contrasted with the corresponding white matter region
contralateral to the hematoma in which
immunofluorescence for fibrinogen was only
present within blood vessels, which was an expected result in
unperfused in situ frozen brains.
|
Water Contents
The two white matter regions adjoining
hematomas that differed in
their physical appearance also differed markedly in their water
contents (Fig 8
). Water content in translucent white
matter was significantly increased at all time points compared with the
water content in all normal-appearing ipsilateral and corresponding
contralateral white matter samples in experimental and control animals
(P<.001). These increases in water content averaged 10% to
15% above posterior ipsilateral and contralateral white matter values.
The water content of the translucent white matter was the same for all
time points. The water content of normal-appearing white matter
directly adjacent to hematomas was also significantly increased
compared with the water content of other normal white matter regions in
experimental animals at 3, 5, and 8 hours. This 6% increase in water
content was less than that observed in translucent white matter.
| Discussion |
|---|
|
|
|---|
This development of perihematomal edema as a result of interstitial serum protein accumulation is similar pathophysiologically to vasogenic35 (or open barrier27 ) edema, in which increased BBB permeability results in the influx of protein molecules into the ECS. Since the plasma protein content of the ECS is normally very low, its accumulation in the ECS causes the osmotic pressure of the interstitial fluid to approach that of plasma, resulting in water movement from blood to brain that produces edema.27 Indeed, a linear correlation between protein and water contents in the ECS after experimental BBB injury has been reported.36
This accumulation of serum proteins in the ECS also provides an
explanation for the prolongation of perihematomal edema after ICH.
Groger and Marmarou37 demonstrated a significant
relationship between the protein concentration of edema fluid and the
rate of edema clearance. In their studies, edema resolution was minimal
within the first 3 days after infusion of a high concentration of
albumin (65 mg/mL), while in contrast, edema was completely
resolved within 72 hours when mock cerebrospinal fluid was infused. In
preliminary neuropathology studies, we observed that white matter near
the hematoma in our model continued to be markedly edematous at 3 days
after blood infusion.10 11 Similarly, in
collagenase-induced ICH and blood infusion models into
rat basal ganglia, water contents that were increased by 4 and 24 hours
remained at this level through 72 hours38 and 4
days,9 respectively. In human ICH, perihematomal edema was
observed for 5 to 7 days after a bleed. This edema can be substantial
with volumes equal to or greater than the hematoma volume itself
(Reference 39, Table 1
).
In human ICH, clot retraction is generally considered to contribute to early perihematomal edema development. Brott et al32 have suggested this mechanism to explain the low densities they observed on CT scans as early as 3 hours after symptom onset. Similarly, others have also implicated clot retraction for the hyperintensities indicative of edema they observed surrounding hyperacute hematomas on T2-weighted MR images.12 33
Several results also suggest that mechanisms other than mass effect are involved in the contribution of blood and/or its serum components to perihematomal edema formation. The strongest evidence is from the demonstration that inflation of a microballoon, to model mass effect alone, failed to produce perihematomal edema at 4 hours even though it markedly reduced CBF to less than 20 mL/100 g per minute.40 In addition, blood produces larger lesions than would be expected from its space-occupying effects alone,41 and Suzuki and Ebina42 reported that blood injections into the caudate nucleus in dogs produced significantly more progressive perilesional sponginess and necrosis compared with inert mass lesions (oil-wax mixture).
At present, the role of ischemia in perihematomal edema development is controversial. Early CBF reductions apparently reflect the immediate and maximal hemodynamic adjustments in brain after an ICH. Nath et al26 described that ischemia persisted only to a marginal degree beyond 10 minutes and had returned to normal within 3 hours, and Yang et al9 found that 50% reductions in CBF at 1 hour had returned to control levels by 4 hours. Similar 50% reductions in CBF in both hemispheres were reported in the cat43 at 5 minutes after basal ganglia hemorrhage. Ropper and Zervas44 reported that their lowest CBF values were 25 to 30 mL/100 g per minute even when large volumes (240 to 280 µL) of blood were injected within 1 second into the caudate nucleus, causing coma in awake rats. These values are well above the accepted threshold blood flow levels for ischemic injury of 15 to 20 mL/100 g per minute.45 Furthermore, these reduced flows were transitory and recovered to baseline by 4 hours. Thus, it appears unlikely that blood flow reduction or "local ischemia" is sufficient in degree and duration to produce the perihematomal edema that we observe.
Our recent brain metabolite studies also support the conclusion that blood flow reductions surrounding hematomas during the early hours after ICH are unlikely to be either severe or prolonged and are unlikely to contribute to the edema we observe. In markedly edematous perihematomal white matter in our ICH model, we observed essentially unchanged ATP at 3 to 8 hours, increased phosphocreatine at 3 and 5 hours, and a fourfold increase in glycogen concentrations by 8 hours after hematoma induction (References 15 and 46 and K.R.W. et al, unpublished data, 1995). These results are suggestive of a reduced metabolic rate in this edematous white matter region. This conclusion is supported by the findings of Nath et al,26 who reported early decreases in the activity of the glycogenolytic enzyme phosphorylase after blood injections in rat caudate.
Finally, in our ongoing studies we observe a continued presence of white matter edema ipsilateral to hematomas and the development of reactive astrocytosis and myelin pallor at 3 days after infusion.10 11 In these white matter regions, eventual glial scar, cyst formation, and atrophy develop,11 similar to the white matter pathology in human ICH.47 Thus, we observe a wide spectrum of pathophysiological and neuropathologic changes in this large-animal lobar ICH model that appear similar to those that occur after ICH in humans. This model should be useful for examination of therapeutic interventions that reduce edema development,48 prevent white matter injury, and improve brain outcome after ICH.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received July 21, 1995; revision received November 21, 1995; accepted December 6, 1995.
| References |
|---|
|
|
|---|
2.
Broderick J, Brott T, Duldner JE, Tomsick T, Huster
G. Volume of intracerebral hemorrhage: a
powerful and easy-to-use predictor of 30-day mortality.
Stroke. 1993;24:987-993.
3.
Lisk DR, Pasteur W, Rhoades H, Putman RD, Grotta
JC. Early presentation of hemispheric
intracerebral hemorrhage: prediction of outcome
and guidelines for treatment allocation. Neurology. 1994;44:133-139.
4. Kase CS, Caplan LR. Intracerebral Hemorrhage. Boston, Mass: Butterworth-Heinemann; 1994.
5. Kaufman HH, Schochet SS. Pathology, pathophysiology, and modeling. In: Kaufman HH, ed. Intracerebral Hematomas. New York, NY: Raven Press Publishers; 1992:13-21.
6. Bullock R, Brock-Utne J, van Dellen J, Blake G. Intracerebral hemorrhage in a primate model: effect on regional cerebral blood flow. Surg Neurol. 1988;29:101-107. [Medline] [Order article via Infotrieve]
7. Bullock R, Mendelow AD, Teasdale GM, Graham DI. Intracranial hemorrhage induced at arterial pressure in the rat, part I. Neurol Res. 1984;6:184-188. [Medline] [Order article via Infotrieve]
8. Hayman LA, McArdle CB, Taber KH, Saleem A, Baskin D, Lee HS, Kirkpatrick JB, Herrick RC, Bryan RN. MR imaging of hyperacute intracranial hemorrhage in the cat. AJNR Am J Neuroradiol. 1989;10:681-688. [Abstract]
9. Yang G-Y, Betz AL, Chenevert TL, Brunberg JA, Hoff JT. Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain-barrier permeability in rats. J Neurosurg. 1994;81:93-102. [Medline] [Order article via Infotrieve]
10. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, Brott TG, Broderick JP. White matter edema in experimental lobar intracerebral hemorrhage. Stroke. 1995;26:178. Abstract.
11. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, Zuccarello M, Lewis A, Brott TG, Broderick JP. Lobar intracerebral hemorrhage model in pigs: neurologic and neuropathologic outcomes and improved brain energy state after hematoma evacuation. J Cereb Blood Flow Metab. 1995;15(suppl 1):S28. Abstract.
12. Dul K, Drayer BP. CT and MR imaging of intracerebral hemorrhage. In: Kase CS, Caplan LR, eds. Intracerebral Hemorrhage. Boston, Mass: Butterworth-Heinemann; 1994:73-98.
13.
Toffol GJ, Biller J, Adams HP. Nontraumatic
intracerebral hemorrhage in young
adults. Arch Neurol. 1987;44:483-485.
14. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE. Experimental intracerebral hemorrhage in pigs: model development and neuropathologic observations. Brain Pathol. 1994;4:513. Abstract.
15. Xi G, Wagner KR, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE. Interstitial serum protein stimulates glycogen synthesis in white matter astrocytes following experimental intracerebral hemorrhage? Soc Neurosci Abstr. 1994;20:418. Abstract.
16. Wagner KR, Myers RE. Topography of brain metabolite concentrations in rhesus monkeys, goats, and cats. Exp Neurol. 1985;89:146-158. [Medline] [Order article via Infotrieve]
17. Wagner KR, Tornheim PA, Eichhold MK. Acute changes in regional cerebral metabolite values following experimental blunt head trauma. J Neurosurg. 1985;63:88-96. [Medline] [Order article via Infotrieve]
18. Wagner KR, Kleinholz M, Myers RE. Delayed neurologic deterioration following anoxia: brain mitochondrial and metabolic consequences. J Neurochem. 1989;52:1407-1417. [Medline] [Order article via Infotrieve]
19. Wagner KR, Kleinholz M, de Courten-Myers, Myers RE. Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH and infarct size. J Cereb Blood Flow Metab. 1992;12:213-222. [Medline] [Order article via Infotrieve]
20. de Courten-Myers GM, Kleinholz M, Wagner KR, Xi G, Myers RE. Efficacious experimental stroke treatment with high-dose methylprednisolone. Stroke. 1994;25:487-493. [Abstract]
21. Yoshikawa T. Atlas of the Brains of Domestic Animals. University Park, Penn: Pennsylvania State University Press; 1968.
22. Clasen RA, Bezkorovainy A, Pandolfi S. Protein and electrolyte changes in experimental cerebral edema. J Neuropathol Exp Neurol. 1982;41:113-128. [Medline] [Order article via Infotrieve]
23. Loberg EM, Torvik A. Uptake of plasma proteins into damaged neurons: an experimental study on cryogenic lesions in rats. Acta Neuropathol (Berl).. 1991;81:479-485. [Medline] [Order article via Infotrieve]
24. Sternberger LA. Immunohistochemistry. 3rd ed. New York, NY: Churchill Livingstone, Inc; 1986.
25. Katayama Y, Becker DB. Early cellular swelling in experimental traumatic brain injury: a phenomenon mediated by excitatory amino acids. Acta Neurochir (Wien). 1990;51(suppl):271-273.
26. Nath FP, Kelly PT, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Effects of experimental intracerebral hemorrhage on blood flow, capillary permeability and histochemistry. J Neurosurg. 1987;66:555-562. [Medline] [Order article via Infotrieve]
27. Betz AL, Iannotti F, Hoff JT. Brain edema: a classification based on blood-brain-barrier integrity. Cerebrovasc Brain Metab Rev.. 1989;1:133-154. [Medline] [Order article via Infotrieve]
28. Kuroiwa T, Shibutani M, Hirasawa H, Okeda R. Hydrostatic pressure versus osmotic pressure in the development of vasogenic brain edema induced by cold injury. Adv Neurol. 1990;52:11-19. [Medline] [Order article via Infotrieve]
29.
Clark RA, Watanabe AT, Bradley WG, Roberts JD.
Acute hematomas: effects of deoxygenation,
hematocrit, and fibrin-clot formation and retraction on T2
shortening. Radiology. 1990;175:201-206.
30. Hayman LA, Tabor KH, Ford JJ, Saleem A, Gurgun M, Mohamed S, Bryan RN. Effect of clot formation and retraction on spin-echo MR images of blood: an in vitro study. AJNR Am J Neuroradiol. 1989;10:1155-1158. [Abstract]
31.
Bradley WG. MR appearance of hemorrhage
in the brain. Radiology. 1993;189:15-26.
32. Brott T, Broderick J, Barsan W, Kothari R, Tomsick T, Spilker J, Huster G. Hyper-acute clot retraction in spontaneous intracerebral hemorrhage. Stroke. 1992;23:141. Abstract.
33. Thulborn KR, Atlas SW. Intracranial hemorrhage. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. New York, NY: Raven Press, Publishers; 1991:175-222.
34. Enzmann DR, Britt RH, Lyons BE, Buxton JL, Wilson DA. Natural history of experimental intracerebral hemorrhage: sonography, computed tomography and neuropathology. AJNR Am J Neuroradiol. 1981;2:517-526. [Abstract]
35. Klatzo I. Neuropathological aspects of brain edema. J Neuropathol Exp Neurol. 1967;26:1-14. [Medline] [Order article via Infotrieve]
36. Kuroiwa T, Cahn R, Juhler M, Goping G, Campbell G, Klatzo I. Role of extracellular proteins in the dynamics of vasogenic brain edema. Acta Neuropathol (Berl).. 1985;66:3-11. [Medline] [Order article via Infotrieve]
37. Groger U, Marmarou A. Importance of protein content in the edema fluid for the resolution of brain edema. In: Long D, Pappius HM, Shigeno T, Gaab MR, eds. Advances in Neurology, Vol 52, Brain Edema: Pathogenesis, Imaging, and Therapy. New York, NY: Raven Press, Publishers; 1990:215-218.
38.
Mun-Bryce S, Kroh FO, White J, Rosenberg GA.
Brain lactate and pH dissociation in edema: 1H- and
31P-NMR in collagenase-induced
hemorrhage in rats. Am J Physiol. 1993;265:R697-R702.
39.
Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M,
Chang CM, Cheung RTF, Fong KY. Treatment of acute cerebral
hemorrhage with intravenous glycerol: a
double-blind, placebo-controlled, randomized trial.
Stroke. 1988;19:991-996.
40. Sinar EJ, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral hemorrhage: effects of a temporary mass lesion. J Neurosurg. 1987;66:568-576. [Medline] [Order article via Infotrieve]
41. Jenkins A, Mendelow AD, Graham DI, Nath FP, Teasdale GM. Experimental intracerebral hematoma: the role of blood constituents in early ischemia. Br J Neurosurg. 1990;4:45-52. [Medline] [Order article via Infotrieve]
42. Suzuki J, Ebina T. Sequential changes in tissue surrounding ICH. In: Pia HW, Longmaid C, Zierski J, eds. Spontaneous Intracerebral Hematomas. Berlin, Germany: Springer; 1980:121-128.
43. Kobari M, Gotoh F, Tomita M, Tanahashi N, Shinohara T, Terayama Y, Mihara B. Bilateral hemispheric reduction of cerebral blood volume and blood flow immediately after experimental cerebral hemorrhage in cats. Stroke. 1988;19:991-996.
44. Ropper AH, Zervas NT. Cerebral blood flow after experimental basal ganglia hemorrhage. Ann Neurol. 1982;2:266-271.
45. Bell BA, Symon L, Branston NM. CBF and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in the baboon. J Neurosurg. 1985;62:31-41. [Medline] [Order article via Infotrieve]
46. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE. Experimental intracerebral hemorrhage: white matter regions adjacent to hematomas differ in pathophysiology and response to hyperglycemia. Soc Neurosci Abstr. 1994;20:418. Abstract.
47. Courville CB. Intracerebral hematoma: its pathology and pathogenesis. Arch Neurol. 1957;77:464-472.
48. Wagner KR, Xi G, Hua Y, Zuccarello M, Banks A, de Courten-Myers GM, Myers RE, Brott TG, Broderick JP. Clot removal following lysis with tissue plasminogen activator markedly reduces perihematomal edema in an intracerebral hemorrhage model. Stroke. 1996;27:183. Abstract.
This article has been cited by other articles:
![]() |
Y. Gu, Y. Hua, R. F. Keep, L. B. Morgenstern, and G. Xi Deferoxamine Reduces Intracerebral Hematoma-Induced Iron Accumulation and Neuronal Death in Piglets Stroke, June 1, 2009; 40(6): 2241 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okauchi, Y. Hua, R. F. Keep, L. B. Morgenstern, and G. Xi Effects of Deferoxamine on Intracerebral Hemorrhage-Induced Brain Injury in Aged Rats Stroke, May 1, 2009; 40(5): 1858 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Arakawa, M.P. Marks, H.M. Do, D.M. Bouley, N. Strobel, T. Moore, and R. Fahrig Experimental Study of Intracranial Hematoma Detection with Flat Panel Detector C-Arm CT AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 766 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.J. Yun, D.G. Na, B.J. Kwon, H.G. Rho, S.-H. Park, Y.-L. Suh, and K.-H. Chang A T1 Hyperintense Perilesional Signal Aids in the Differentiation of a Cavernous Angioma from Other Hemorrhagic Masses AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 494 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, G. Sun, J. Zhang, R. Strong, P. K. Dash, Y. W. Kan, J. C. Grotta, and J. Aronowski Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage Stroke, December 1, 2007; 38(12): 3280 - 3286. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Herweh, E. Juttler, P. D. Schellinger, E. Klotz, E. Jenetzky, B. Orakcioglu, K. Sartor, and P. Schramm Evidence Against a Perihemorrhagic Penumbra Provided by Perfusion Computed Tomography Stroke, November 1, 2007; 38(11): 2941 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, October 16, 2007; 116(16): e391 - e413. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, June 1, 2007; 38(6): 2001 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Wagner Modeling Intracerebal Hemorrhage: Glutamate, Nuclear Factor-{kappa}B Signaling and Cytokines Stroke, February 1, 2007; 38(2): 753 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Delgado, J. Alvarez-Sabin, S. Abilleira, E. Santamarina, F. Purroy, J. F. Arenillas, C. A. Molina, I. Fernandez-Cadenas, A. Rosell, and J. Montaner Plasma d-dimer predicts poor outcome after acute intracerebral hemorrhage. Neurology, July 11, 2006; 67(1): 94 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
NINDS ICH Workshop Participants Priorities for Clinical Research in Intracerebral Hemorrhage: Report From a National Institute of Neurological Disorders and Stroke Workshop Stroke, March 1, 2005; 36(3): e23 - e41. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Belayev, I. Saul, R. Busto, K. Danielyan, A. Vigdorchik, L. Khoutorova, and M. D. Ginsberg Albumin Treatment Reduces Neurological Deficit and Protects Blood-Brain Barrier Integrity After Acute Intracortical Hematoma in the Rat Stroke, February 1, 2005; 36(2): 326 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alvarez-Sabin, P. Delgado, S. Abilleira, C. A. Molina, J. Arenillas, M. Ribo, E. Santamarina, M. Quintana, J. Monasterio, and J. Montaner Temporal Profile of Matrix Metalloproteinases and Their Inhibitors After Spontaneous Intracerebral Hemorrhage: Relationship to Clinical and Radiological Outcome Stroke, June 1, 2004; 35(6): 1316 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Norris Steroids May Have a Role in Stroke Therapy Stroke, January 1, 2004; 35(1): 228 - 229. [Full Text] [PDF] |
||||
![]() |
S. R. Platt and L. Garosi Canine Cerebrovascular Disease: Do Dogs Have Strokes? J. Am. Anim. Hosp. Assoc., July 1, 2003; 39(4): 337 - 342. [Full Text] [PDF] |
||||
![]() |
A. K. Kamal, J. P. Dyke, J. M. Katz, B. Liberato, C. G. Filippi, R. D. Zimmerman, and A. M. Ulug Temporal Evolution of Diffusion after Spontaneous Supratentorial Intracranial Hemorrhage AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 895 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mayer Ultra-Early Hemostatic Therapy for Intracerebral Hemorrhage Stroke, January 1, 2003; 34(1): 224 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gebel Jr, E. C. Jauch, T. G. Brott, J. Khoury, L. Sauerbeck, S. Salisbury, J. Spilker, T. A. Tomsick, J. Duldner, and J. P. Broderick Natural History of Perihematomal Edema in Patients With Hyperacute Spontaneous Intracerebral Hemorrhage Stroke, November 1, 2002; 33(11): 2631 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hua, T. Schallert, R. F. Keep, J. Wu, J. T. Hoff, and G. Xi Behavioral Tests After Intracerebral Hemorrhage in the Rat Stroke, October 1, 2002; 33(10): 2478 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Carhuapoma, P. B. Barker, D. F. Hanley, P. Wang, and N. J. Beauchamp Human Brain Hemorrhage: Quantification of Perihematoma Edema by Use of Diffusion-Weighted MR Imaging AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1322 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Castillo, A. Davalos, J. Alvarez-Sabin, J. M. Pumar, R. Leira, Y. Silva, J. Montaner, and C.S. Kase Molecular signatures of brain injury after intracerebral hemorrhage Neurology, February 26, 2002; 58(4): 624 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sjoblom, H.-G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, L. Stigendal, D. Stockelberg, A. Taghavi, L. Wallrup, et al. Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study Stroke, November 1, 2001; 32(11): 2567 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.B. Morgenstern, A.M. Demchuk, D.H. Kim, R.F. Frankowski, and J.C. Grotta Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage Neurology, May 22, 2001; 56(10): 1294 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Qureshi, S. Tuhrim, J. P. Broderick, H. H. Batjer, H. Hondo, and D. F. Hanley Spontaneous Intracerebral Hemorrhage N. Engl. J. Med., May 10, 2001; 344(19): 1450 - 1460. [Full Text] [PDF] |
||||
![]() |
M. Xue, M. R. Del Bigio, and J. P. Muizelaar Intracortical Hemorrhage Injury in Rats : Relationship Between Blood Fractions and Brain Cell Death Editorial Comment: Relationship Between Blood Fractions and Brain Cell Death Stroke, July 1, 2000; 31(7): 1721 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gebel, T. G. Brott, C. A. Sila, T. A. Tomsick, E. Jauch, S. Salisbury, J. Khoury, R. Miller, A. Pancioli, J. E. Duldner, et al. Decreased Perihematomal Edema in Thrombolysis-Related Intracerebral Hemorrhage Compared With Spontaneous Intracerebral Hemorrhage Stroke, March 1, 2000; 31(3): 596 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hickenbottom, J. C. Grotta, R. Strong, L. A. Denner, J. Aronowski, and R. L. Macdonald Nuclear Factor-{kappa}B and Cell Death After Experimental Intracerebral Hemorrhage in Rats • Editorial Comment Stroke, November 1, 1999; 30 (11): 2472 - 2478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zuccarello, T. Brott, L. Derex, R. Kothari, L. Sauerbeck, J. Tew, H. Van Loveren, H.-S. Yeh, T. Tomsick, A. Pancioli, et al. Early Surgical Treatment for Supratentorial Intracerebral Hemorrhage : A Randomized Feasibility Study Stroke, September 1, 1999; 30(9): 1833 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. F. Cheung, S. A. Mayer, and R. L. Van Heertum SPECT-Derived Relative Perfusion Defect and CT-Derived Hypodense Region in Acute Intracerebral Hemorrhage • Response Stroke, July 1, 1999; 30 (7): 1490 - 1493. [Full Text] [PDF] |
||||
![]() |
A. R. Zazulia, M. N. Diringer, C. P. Derdeyn, and W. J. Powers Progression of Mass Effect After Intracerebral Hemorrhage Stroke, June 1, 1999; 30(6): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Qureshi, D. A. Wilson, D. F. Hanley, and R. J. Traystman No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage Neurology, January 1, 1999; 52(2): 266 - 266. [Abstract] [Full Text] |
||||
![]() |
G. Xi, K. R. Wagner, R. F. Keep, Y. Hua, G. M. de Courten-Myers, J. P. Broderick, T. G. Brott, J. T. Hoff, and J. P. Muizelaar Role of Blood Clot Formation on Early Edema Development After Experimental Intracerebral Hemorrhage • Editorial Comment Stroke, December 1, 1998; 29(12): 2580 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mayer, A. Lignelli, M. E. Fink, D. B. Kessler, C. E. Thomas, R. Swarup, and R. L. Van Heertum Perilesional Blood Flow and Edema Formation in Acute Intracerebral Hemorrhage : A SPECT Study Stroke, September 1, 1998; 29(9): 1791 - 1798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Altumbabic, J. Peeling, M. R. Del Bigio, and R. L. Macdonald Intracerebral Hemorrhage in the Rat: Effects of Hematoma Aspiration • Editorial Comment Stroke, September 1, 1998; 29(9): 1917 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Figueroa, R. F. Keep, A. L. Betz, J. T. Hoff, and J. H. Garcia Plasminogen Activators Potentiate Thrombin-Induced Brain Injury • Editorial Comment Stroke, June 1, 1998; 29(6): 1202 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gebel, C. A. Sila, M. A. Sloan, C. B. Granger, K. W. Mahaffey, J. Weisenberger, C. L. Green, H. D. White, J. M. Gore, W. D. Weaver, et al. Thrombolysis-Related Intracranial Hemorrhage : A Radiographic Analysis of 244 Cases From the GUSTO-1 Trial With Clinical Correlation Stroke, March 1, 1998; 29(3): 563 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Lyden, C. Jackson-Friedman, L. Lonzo-Doktor, and J. P. Muizelaar Medical Therapy for Intracerebral Hematoma With the {gamma}-Aminobutyric Acid-A Agonist Muscimol Stroke, February 1, 1997; 28(2): 387 - 391. [Abstract] [Full Text] |
||||
![]() |
M. R. D. Bigio, H.-J. Yan, R. Buist, J. Peeling, and G. J. del Zoppo Experimental Intracerebral Hemorrhage in Rats: Magnetic Resonance Imaging and Histopathological Correlates Stroke, December 1, 1996; 27(12): 2312 - 2320. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |